Evaluated by: David B. Kaminsky, M.D., FIAC, August 8, 2017
Original release date: August 8, 2017
Access to this course expires on: May 5, 2020
Faculty: Mara Rendi, M.D., Ph.D.
Practicing academic and community pathologists, pathologists-in-training and breast pathologists
- Diagnose and order appropriate ancillary tests for special-type breast cancers with a different prognosis than invasive carcinoma NOS so that they may adequately educate clinicians on these important histologic subtypes
- Recognize a variety of triple-negative breast carcinomas as well as determine appropriate immunohistochemical and molecular testing important for accurate subclassification
- Be able to diagnose rare breast carcinoma subtypes that are often not seen outside of a consultation practice so that they may recognize these entities and their clinical implications
To earn CME and SAM credit, all learners must take a content-based exam and achieve a minimum score of 80%. If learners do not achieve a passing score of 80%, they have the option to retake the exam. After you pass the test and complete the evaluation, your certificate of completion will be available to view and print by clicking here.